Edition:
India

People: ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

55.86USD
25 Nov 2020
Change (% chg)

-- (--)
Prev Close
$55.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
451,921
52-wk High
$58.67
52-wk Low
$30.02

Yang, Michael 

Mr. Michael J. Yang serves as Executive Vice President, Chief Commercial Officer of the Company. Mr. Yang is our Executive Vice President, Chief Commercial Officer and has been with our company since March 2017. Mr. Yang joined us from Janssen Pharmaceutical Companies of Johnson & Johnson, where he served as President of Janssen Biotech Inc. and was responsible for building Janssen’s U.S. Immunology business, generating more than $8 billion in annual revenues. Mr. Yang began his career at Johnson & Johnson in 1997 and held numerous senior commercial positions such as President, CNS where he was responsible for growing the anti-psychotic long-acting therapy portfolio. His broad background of commercialization and general management experience also includes roles as the Worldwide General Manager of the Medical Device companies of Therakos, Inc and Veridex, LLC, where he launched new platforms, expanded global revenues and diversified the product lines. Prior to that, Mr. Yang was Vice President of Sales and Marketing, Oncology at Ortho Biotech Inc. He currently serves on the board of directors of Akcea Therapeutics, Inc. Mr. Yang earned his B.S. in business administration, marketing from San Diego State University.

Basic Compensation

Total Annual Compensation, USD 500,701
Restricted Stock Award, USD 1,291,320
Long-Term Incentive Plans, USD --
All Other, USD 1,151,800
Fiscal Year Total, USD 2,943,820

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 120,000 1,622,230.00
Name Fiscal Year Total

Stephen Biggar

319,959

Srdjan Stankovic

5,088,270

Stephen Davis

7,631,250

Elena Ridloff

1,990,870

Austin Kim

1,906,130

Gudarz Davar

--
As Of  31 Dec 2019